Accelerated Phase Myeloproliferative Neoplasm

general

Rapid progression of a myeloproliferative neoplasm, characterized by the presence of myeloblasts accounting for 10-19% of the peripheral blood white cells or the nucleated cells in the bone marrow.

32

Centers

24

Active Trials

$7.3B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Accelerated Phase Myeloproliferative Neoplasm(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
55.0
2
NCI Comprehensive
Active Research Program
55.0
355.0
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Clinical
Active Research Program
55.0
7
NCI Comprehensive
Active Research Program
55.0
8
NCI Comprehensive
Active Research Program
55.0
9
Active Research Program
55.0
10
Active Research Program
55.0
11
NCI Comprehensive
12
NCI Comprehensive
13
14
NCI Comprehensive
15
16
17
18
NCI Comprehensive
19
NCI Comprehensive
20
21
NCI Comprehensive
22
NCI Comprehensive
23
NCI Comprehensive
24
NCI Comprehensive
25
26
27
28
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
29
30
31
32

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →